Carolina Caserta

Myeloid cell‐based delivery of IFN‐γ reprograms the leukemia microenvironment and induces anti‐tumoral immune responses

L. Naldini, A. Mucci, F. Sanvito, 2021, EMBO molecular medicine.

Longitudinal single-cell profiling of chemotherapy response in acute myeloid leukemia

P. Rancoita, C. Di Serio, F. Ciceri, 2023, Nature Communications.

miR-126 identifies a quiescent and chemo-resistant human B-ALL cell subset that correlates with minimal residual disease

M. Valsecchi, Paola Capasso, D. Silvestri, 2023, Leukemia.

The transcription factor HIF2α partakes in the differentiation block of acute myeloid leukemia

N. Coltella, C. Tresoldi, Daniela Magliulo, 2023, EMBO molecular medicine.